Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes

• US 7,917,196 B2
• Filed: 05/09/2005
• Issued: 03/29/2011
• Est. Priority Date: 05/09/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Meyer, Scott A., Zhang, Yi, McCabe, Aaron R., Ricci, Carlos Alberto, Stahmann, Jeffrey E., Yu, Yinghong
• Primary Examiner(s): Layno; Carl H.
• Assistant Examiner(s): Heller; Tammie K
• Application Number:
  US11/125,020
• Publication Number:
  US 20060253044A1
• Time in Patent Office: 2,150 Days
• Field of Search: 600/512
• US Class Current: 600/512
• CPC Class Codes: A61B 5/341 Vectorcardiography [VCG]
• CPC Class Codes: A61B 5/7203 for noise prevention, reduction or removal

Abstract

Cardiac monitoring and/or stimulation methods and systems provide for monitoring, diagnosing, defibrillation and pacing therapies, or a combination of these capabilities, including cardiac systems incorporating or cooperating with neuro-stimulating devices, drug pumps, or other therapies. Embodiments relate generally to implantable medical devices employing automated cardiac activation sequence monitoring and/or tracking for arrhythmia discrimination. Embodiments are directed to devices and methods involving sensing a plurality of composite cardiac signals using a plurality of implantable electrodes. A source separation is performed using the sensed plurality of composite cardiac signals and the separation produces one or more cardiac signal vectors associated with one or more cardiac activation sequences that is indicative of ischemia. A change of the one or more cardiac signal vectors is detected using the one or more cardiac signal vectors. Cardiac arrhythmias are discriminated using the one or more cardiac signal vectors.

Claims

1. A cardiac method, comprising:

sensing a plurality of composite cardiac signals using a plurality of implantable electrodes;

performing a source separation using the sensed plurality of composite cardiac signals;

producing one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences based on the source separation;

determining one or more orientations of the one or more cardiac signal vectors; and

discriminating between supra-ventricular tachycardia (SVT) and ventricular tachycardia (VT) using the one or more orientations of the one or more cardiac signal vectors,

wherein discriminating between SVT and VT comprises determining whether the one or more orientations of the one or more cardiac signal vectors are within a vector orientation range established based on one or more previous SVT events, and performing the source separation, producing the one or more cardiac signal vectors, determining the one or more orientations, and discriminating are each performed at least in part by circuitry of a medical system.

2. The method of claim 1, wherein discriminating between SVT and VT further comprises comparing the one or more orientations of the one or more cardiac signal vectors to a baseline.

3. The method of claim 2, further comprising establishing the baseline as a cardiac activation sequence vector orientation based on patient information.

4. The method of claim 1, wherein the medical system comprises an implantable device.

5. The method of claim 1, further comprising detecting a tachycardia and determining whether the tachycardia is an SVT or a VT.

6. A cardiac system, comprising:

a plurality of implantable electrodes configured for sensing a composite signal, thereby providing a plurality of composite cardiac signals;

a housing configured for implantation in a patient;

a memory provided in the housing; and

a controller provided in the housing and coupled to the memory and the plurality of implantable electrodes, the controller configured to perform a source separation using the sensed plurality of composite cardiac signals, the source separation producing one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences, determine one or more orientations of the one or more cardiac signal vectors, and to discriminate between supra-ventricular tachycardia (SVT) and ventricular tachycardia (VT) using the one or more orientations of the one or more cardiac signal vectors;

wherein the controller is further configured to establish a vector orientation range based on previous SVT events and discriminate between SVT and VT based on whether the one or more orientations of the one or more cardiac signal vectors are within the vector orientation range.

7. The system of claim 6, comprising therapy circuitry coupled to the controller and configured to deliver a cardiac therapy in response to the discrimination between SVT and VT.

8. The system of claim 6, comprising a signal processor provided in a patient-external device or system, the signal processor and the controller coupled to respective communication devices to facilitate wireless communication between the signal processor and controller.

9. The system of claim 6, wherein the memory is configured to store a baseline and the controller is further configured to compare the one or more orientations of the one or more cardiac signal vectors to the baseline to discriminate between SVT and VT.

10. The system of claim 9, wherein the controller is further configured to establish the baseline based on patient information.

11. The system of claim 6, wherein the controller is configured to detect a tachycardia event and then determine the one or more orientations of the one or more cardiac signal vectors and discriminate between SVT and VT based on the detection of the tachycardia event.

12. The system of claim 6, wherein the plurality of composite cardiac signals are sensed as far-field signals.

13. The system of claim 6, wherein the plurality of comprises one or more electrodes located on the housing and one or more electrodes located on a lead coupled to the housing.

14. The system of claim 6, wherein the controller is configured to perform the source separation by using a blind source separation algorithm.

15. A cardiac method, comprising:

sensing a plurality of composite cardiac signals using a plurality of implantable electrodes;

performing a source separation using the sensed plurality of composite cardiac signals;

producing one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences based on the source separation;

determining one or more orientations of the one or more cardiac signal vectors;

establishing a vector orientation range based on a plurality of previous supra-ventricular tachycardia (SVT) events;

discriminating between SVT and ventricular tachycardia (VT) using the one or more orientations of the one or more cardiac signal vectors, wherein performing the source separation, producing the one or more cardiac signal vectors, determining the one or more orientations, and discriminating are each performed at least in part by circuitry of a medical system; and

detecting a tachycardia arrhythmia event, wherein discriminating between SVT and VT is performed based on the detection of the tachycardia arrhythmia event and further comprises;

determining that the tachycardia arrhythmia event comprises SVT if the one or more orientations of the one or more cardiac signal vectors are within the vector orientation range; and

determining that the tachycardia arrhythmia event comprises VT if the one or more orientations of the one or more cardiac signal vectors are not within the vector orientation range.